Securities code: 000952 securities abbreviation: Hubei Guangji Pharmaceutical Co.Ltd(000952) Announcement No.: 2022-001 Hubei Guangji Pharmaceutical Co.Ltd(000952)
About the restricted stock incentive plan in 2021
Announcement on obtaining the approval of Hubei SASAC
The company and all members of the board of directors guarantee that the information disclosed is true, accurate and complete without false records, misleading statements or major omissions.
Hubei Guangji Pharmaceutical Co.Ltd(000952) (hereinafter referred to as ” Hubei Guangji Pharmaceutical Co.Ltd(000952) ” and “the company”) held the 10th (Interim) meeting of the 10th board of directors on November 12, 2021 The 9th (Interim) meeting of the 10th board of supervisors deliberated and adopted other relevant proposals, such as the proposal on Hubei Guangji Pharmaceutical Co.Ltd(000952) 2021 restricted stock incentive plan (Draft) and its summary, the proposal on Hubei Guangji Pharmaceutical Co.Ltd(000952) 2021 restricted stock incentive plan implementation assessment management measures, etc, See the company’s designated information disclosure media and cninfo.com on November 13, 2021 for details（ http://www.cn.info.com..cn. ）Disclosure announcement.
On December 31, 2021, the company received the reply of the state owned assets supervision and Administration Commission of the people’s Government of Hubei Province on Hubei Guangji Pharmaceutical Co.Ltd(000952) implementing the restricted stock incentive plan (e.g. Zi kaofen [2021] No. 69), and agreed in principle to Hubei Guangji Pharmaceutical Co.Ltd(000952) implementing the restricted stock incentive plan.
Matters related to the company’s incentive plan can only be implemented after being submitted to the general meeting of shareholders for deliberation and approval. The company will actively promote relevant work and timely fulfill the obligation of information disclosure in strict accordance with the company law of the people’s Republic of China, the securities law of the people’s Republic of China, the measures for the administration of equity incentive of listed companies and other relevant provisions. It is hereby announced.
Hubei Guangji Pharmaceutical Co.Ltd(000952) board of directors January 4, 2022
